Shell Asset Management’s Boston Scientific BSX Stock Holding History

Shell Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.71M	Sell	27,732 -7,501	-21%	-$777K	0.27%	68
2025 Q2	$3.78M	Buy	35,233 +14,779	+72%	+$1.5M	0.13%	159
2025 Q1	$2.06M	Sell	20,454 -2,666	-12%	-$268K	0.1%	196
2024 Q4	$2.06M	Buy	23,120 +5,626	+32%	+$495K	0.09%	202
2024 Q3	$1.47M	Buy	+17,494	New	+$1.38M	0.06%	246
2024 Q1	$504K	Sell	6,544 -5,171	-44%	-$332K	0.02%	465
2023 Q4	$677K	Sell	11,715 -7,447	-39%	-$398K	0.03%	413
2023 Q3	$1.01M	Sell	19,162 -459	-2%	-$24.1K	0.04%	352
2023 Q2	$1.06M	Sell	19,621 -2,459	-11%	-$128K	0.04%	347
2023 Q1	$1.1M	Sell	22,080 -146	-0.7%	-$6.88K	0.05%	345
2022 Q4	$1.03M	Sell	22,226 -5,175	-19%	-$224K	0.05%	361
2022 Q3	$1.06M	Sell	27,401 -6,755	-20%	-$271K	0.04%	359
2022 Q2	$1.27M	Buy	34,156 +474	+1%	+$19.3K	0.04%	376
2022 Q1	$1.49M	Buy	33,682 +1,343	+4%	+$58.2K	0.04%	387
2021 Q4	$1.37M	Buy	32,339 +6,120	+23%	+$257K	0.03%	452
2021 Q3	$1.14M	Sell	26,219 -2,449	-9%	-$108K	0.03%	467
2021 Q2	$1.23M	Sell	28,668 -30,205	-51%	-$1.27M	0.02%	485
2021 Q1	$2.27M	Buy	58,873 +1,330	+2%	+$50.3K	0.05%	328
2020 Q4	$2.07M	Buy	57,543 +4,607	+9%	+$166K	0.04%	376
2020 Q3	$2.02M	Buy	52,936 +5,375	+11%	+$207K	0.05%	340
2020 Q2	$1.67M	Sell	47,561 -38,915	-45%	-$1.4M	0.04%	349
2020 Q1	$2.82M	Sell	86,476 -8,602	-9%	-$336K	0.08%	253
2019 Q4	$4.3M	Sell	95,078 -8,254	-8%	-$345K	0.09%	250
2019 Q3	$4.21M	Sell	103,332 -12,297	-11%	-$521K	0.1%	244
2019 Q2	$4.97M	Sell	115,629 -109,080	-49%	-$4.2M	0.11%	221
2019 Q1	$8.62M	Buy	224,709 +103,487	+85%	+$3.95M	0.19%	142
2018 Q4	$4.28M	Sell	121,222 -42,801	-26%	-$1.55M	0.11%	228
2018 Q3	$6.32M	Sell	164,023 -7,127	-4%	-$249K	0.12%	198
2018 Q2	$5.6M	Buy	171,150 +15,903	+10%	+$480K	0.11%	221
2018 Q1	$4.24M	Hold	155,247	–	–	0.08%	257
2017 Q4	$3.85M	Buy	155,247 +13,420	+9%	+$370K	0.08%	267
2017 Q3	$4.14M	Sell	141,827 -19,354	-12%	-$534K	0.09%	245
2017 Q2	$4.47M	Buy	161,181 +6,539	+4%	+$174K	0.1%	235
2017 Q1	$3.85M	Sell	154,642 -10,748	-6%	-$261K	0.08%	255
2016 Q4	$3.58M	Sell	165,390 -6,396	-4%	-$140K	0.08%	255
2016 Q3	$4.09M	Sell	171,786 -3,872	-2%	-$92.4K	0.08%	263
2016 Q2	$4.11M	Buy	175,658 +83,606	+91%	+$1.81M	0.1%	238
2016 Q1	$1.73M	Sell	92,052 -28,431	-24%	-$499K	0.04%	415
2015 Q4	$2.22M	Sell	120,483 -170,628	-59%	-$3.06M	0.05%	355
2015 Q3	$3.44M	Buy	291,111 +113,020	+63%	+$1.93M	0.05%	304
2015 Q2	$3.15M	Sell	178,091 -15,978	-8%	-$286K	0.06%	303
2015 Q1	$3.44M	Sell	194,069 -66,824	-26%	-$1.06M	0.06%	300
2014 Q4	$3.46M	Sell	260,893 -30,218	-10%	-$386K	0.06%	316
2014 Q3	$3.44M	Sell	291,111 -19,865	-6%	-$250K	0.05%	315
2014 Q2	$3.97M	Buy	310,976 +2,013	+0.7%	+$26.2K	0.06%	273
2014 Q1	$4.18M	Sell	308,963 -7,243	-2%	-$95.1K	0.07%	258
2013 Q4	$3.8M	Sell	316,206 -105,232	-25%	-$1.24M	0.06%	282
2013 Q3	$4.95M	Sell	421,438 -729,431	-63%	-$7.89M	0.09%	241
2013 Q2	$10.7M	Buy	+1,150,869	New	+$9.76M	0.2%	109

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Shell Asset Management's BSX Position: Q3 2025 in Review

Shell Asset Management reduced its Boston Scientific (BSX) stake by 21% in Q3 2025, selling an estimated $777K and leaving 27,732 shares worth $2.71M. The position accounts for 0.27% of the portfolio, ranked #68.

Shell Asset Management first reported a position in BSX in Q2 2013 and has held it in 49 quarters since. The position peaked at $10.7M in Q2 2013. 1,709 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Shell Asset Management held 27,732 shares of Boston Scientific worth $2.71M as of Q3 2025.
Shell Asset Management sold 7,501 Boston Scientific shares in Q3 2025, an estimated $777K.
Boston Scientific made up 0.27% of Shell Asset Management's portfolio in Q3 2025, its #68 holding.
Shell Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 49 quarters since.
Shell Asset Management's Boston Scientific position peaked at $10.7M in Q2 2013.
1,709 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.